|
Investment Securities (Tables)
|
12 Months Ended |
|
Dec. 31, 2013
|
| Investment Securities |
|
| Schedule of marketable investment securities, restricted cash and cash equivalents, and other investments |
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2013 |
|
2012 |
|
|
|
(In thousands)
|
|
|
Marketable investment securities—current: |
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
833,791 |
|
$ |
654,096 |
|
|
VRDNs |
|
|
34,705 |
|
|
66,145 |
|
|
Strategic equity securities |
|
|
33,613 |
|
|
56,288 |
|
|
Other |
|
|
84,424 |
|
|
39,422 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Total marketable investment securities—current |
|
|
986,533 |
|
|
815,951 |
|
|
Restricted marketable investment securities(1) |
|
|
7,965 |
|
|
7,529 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Total |
|
|
994,498 |
|
|
823,480 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents(1) |
|
|
8,172 |
|
|
21,516 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Other investments—noncurrent: |
|
|
|
|
|
|
|
|
Cost method |
|
|
25,977 |
|
|
27,711 |
|
|
Equity method |
|
|
143,794 |
|
|
155,500 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Total other investments—noncurrent |
|
|
169,771 |
|
|
183,211 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Total marketable investment securities, restricted cash and cash equivalents, and other investments |
|
$ |
1,172,441 |
|
$ |
1,028,207 |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
- (1)
- Restricted marketable investment securities and restricted cash and cash equivalents are included in "Restricted cash and marketable investment securities" in our Consolidated Balance Sheets.
|
| Schedule of unrealized gains (losses) on marketable investment securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
Amortized
Cost |
|
Estimated
Fair Value |
|
|
|
Gains |
|
Losses |
|
|
|
(In thousands)
|
|
|
As of December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
833,888 |
|
$ |
227 |
|
$ |
(324 |
) |
$ |
833,791 |
|
|
VRDNs |
|
|
34,705 |
|
|
— |
|
|
— |
|
|
34,705 |
|
|
Other (including restricted) |
|
|
92,876 |
|
|
14 |
|
|
(501 |
) |
|
92,389 |
|
|
Equity securities—strategic |
|
|
15,272 |
|
|
18,341 |
|
|
— |
|
|
33,613 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total marketable investment securities |
|
$ |
976,741 |
|
$ |
18,582 |
|
$ |
(825 |
) |
$ |
994,498 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
As of December 31, 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
653,812 |
|
$ |
591 |
|
$ |
(307 |
) |
$ |
654,096 |
|
|
VRDNs |
|
|
66,145 |
|
|
— |
|
|
— |
|
|
66,145 |
|
|
Other (including restricted) |
|
|
46,946 |
|
|
5 |
|
|
— |
|
|
46,951 |
|
|
Equity securities—strategic |
|
|
21,214 |
|
|
35,074 |
|
|
— |
|
|
56,288 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total marketable investment securities |
|
$ |
788,117 |
|
$ |
35,670 |
|
$ |
(307 |
) |
$ |
823,480 |
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| Schedule of available-for-sale securities in continuous unrealized loss position by length of time and their fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2013 |
|
2012 |
|
|
|
Fair
Value |
|
Unrealized
Losses |
|
Fair
Value |
|
Unrealized
Losses |
|
|
|
(In thousands)
|
|
|
Less than 12 months |
|
$ |
571,592 |
|
$ |
(825 |
) |
$ |
275,587 |
|
$ |
(288 |
) |
|
12 months or more |
|
|
— |
|
|
— |
|
|
12,963 |
|
|
(19 |
) |
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
571,592 |
|
$ |
(825 |
) |
$ |
288,550 |
|
$ |
(307 |
) |
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| Schedule of fair value measurements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
|
|
2013 |
|
2012 |
|
|
|
Total |
|
Level 1 |
|
Level 2 |
|
Total |
|
Level 1 |
|
Level 2 |
|
|
|
(In thousands)
|
|
|
Cash equivalents (including restricted) |
|
$ |
548,714 |
|
$ |
49,338 |
|
$ |
499,376 |
|
$ |
533,943 |
|
$ |
23,621 |
|
$ |
510,322 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
833,791 |
|
$ |
— |
|
$ |
833,791 |
|
$ |
654,096 |
|
$ |
— |
|
$ |
654,096 |
|
|
VRDNs |
|
|
34,705 |
|
|
— |
|
|
34,705 |
|
|
66,145 |
|
|
— |
|
|
66,145 |
|
|
Other (including restricted) |
|
|
92,389 |
|
|
— |
|
|
92,389 |
|
|
46,951 |
|
|
— |
|
|
46,951 |
|
|
Equity securities—strategic |
|
|
33,613 |
|
|
33,613 |
|
|
— |
|
|
56,288 |
|
|
56,288 |
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total marketable investment securities |
|
$ |
994,498 |
|
$ |
33,613 |
|
$ |
960,885 |
|
$ |
823,480 |
|
$ |
56,288 |
|
$ |
767,192 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|